Treatment of Early Childhood Caries Using Silver Diammine Fluoride and Sodium Fluoride Tricalciumphosphate and the Effects on Oral Health Related Quality of Life

Sponsor
Universiti Sains Malaysia (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05772039
Collaborator
3M ESPE (Industry), SDI Limited (Other)
72
1
6
18.9
3.8

Study Details

Study Description

Brief Summary

There is still a need for the assessment of different minimal intervention strategies and treatments focusing on the prevention and arrest of carious lesions of primary molars The evidence-based clinical practice guideline on non-restorative treatments for cavitated carious lesions advocate the use of silver diammine fluoride biannually for high caries risk patients

Condition or Disease Intervention/Treatment Phase
  • Drug: Topical application of 38% Silver Diammine Fluoride Solution
  • Drug: Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish
Phase 4

Detailed Description

Although SDF has been proven to be highly effective in carious lesion arrest and prevention, the staining effect, metallic taste due to silver content and the minimal mucosal irritation have been noted as primary cause of disinterest among clinicians in the use of this material.

The use of NaF-fTCP as a caries preventive material has not been studied widely. The importance of oral hygiene education and diet modification to achieve an effective caries control has been widely discussed. The off-label use of NaF-fTCP as a caries arresting agent has not been studied on primary dentition. There is a dearth of evidence regarding the effectiveness of NaF-fTCP towards caries arrest and prevention in pragmatic settings.

A comparison between the SDF and NaF-fTCP application on the cavitated carious primary molars and their effect on the oral health-related quality of life of the children has not been published in the literature.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Pragmatic randomized controlled trialPragmatic randomized controlled trial
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Minimally Invasive Treatment Approach for Early Childhood Caries Using Silver Diammine Fluoride and Sodium Fluoride With Functionalized Tricalcium Phosphate and Their Effects on Oral Health Related Quality of Life: A Pragmatic Randomized Control Trial
Actual Study Start Date :
Jan 18, 2022
Anticipated Primary Completion Date :
Jul 15, 2023
Anticipated Study Completion Date :
Aug 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Topical application of 38% Silver Diammine Fluoride Solution at Baseline

SDF is known for its corrosive nature therefore a plastic container or dappen dish will be used. 1 drop (0.05 ml) will be dispensed on a plastic container. 1 drop (2.24 F-ion mg/dose) SDF treats up to 5 tooth surfaces. Ultrafine microbrushes will be used to apply varnish.

Drug: Topical application of 38% Silver Diammine Fluoride Solution
Application of petroleum jelly on lips and around the mouth for prevention of temporary silver tattoo. Before SDF application, the affected area will be thoroughly dried and isolated using the cotton rolls or dri-angle. Isolation throughout the procedure and following three minutes is considered most desirable. The varnish should be allowed to be in place for 60 seconds. This is the most critical step in the process. Applied varnish will be dried with gentle flow of compressed air. SDF will be applied with a microbrush to all carious lesions and to all pits and fissures on posterior (molar) teeth for 60 seconds. To avoid gingival or mucosal irritation, contact of varnish with any oral tissue other than affected area will be avoided. If the application time is shorter due to unforeseen reasons reapplication will be considered.
Other Names:
  • Riva Star
  • 38% Silver Diammine fluoride
  • SDF
  • Advanatge Arrest
  • Saforide
  • Active Comparator: Topical application of 38% Silver Diammine Fluoride Solution at 6 months

    SDF is known for its corrosive nature therefore a plastic container or dappen dish will be used. 1 drop (0.05 ml) will be dispensed on a plastic container. 1 drop (2.24 F-ion mg/dose) SDF treats up to 5 tooth surfaces. Ultrafine microbrushes will be used to apply varnish.

    Drug: Topical application of 38% Silver Diammine Fluoride Solution
    Application of petroleum jelly on lips and around the mouth for prevention of temporary silver tattoo. Before SDF application, the affected area will be thoroughly dried and isolated using the cotton rolls or dri-angle. Isolation throughout the procedure and following three minutes is considered most desirable. The varnish should be allowed to be in place for 60 seconds. This is the most critical step in the process. Applied varnish will be dried with gentle flow of compressed air. SDF will be applied with a microbrush to all carious lesions and to all pits and fissures on posterior (molar) teeth for 60 seconds. To avoid gingival or mucosal irritation, contact of varnish with any oral tissue other than affected area will be avoided. If the application time is shorter due to unforeseen reasons reapplication will be considered.
    Other Names:
  • Riva Star
  • 38% Silver Diammine fluoride
  • SDF
  • Advanatge Arrest
  • Saforide
  • Active Comparator: Topical application of 38% Silver Diammine Fluoride Solution at 12 months

    SDF is known for its corrosive nature therefore a plastic container or dappen dish will be used. 1 drop (0.05 ml) will be dispensed on a plastic container. 1 drop (2.24 F-ion mg/dose) SDF treats up to 5 tooth surfaces. Ultrafine microbrushes will be used to apply varnish.

    Drug: Topical application of 38% Silver Diammine Fluoride Solution
    Application of petroleum jelly on lips and around the mouth for prevention of temporary silver tattoo. Before SDF application, the affected area will be thoroughly dried and isolated using the cotton rolls or dri-angle. Isolation throughout the procedure and following three minutes is considered most desirable. The varnish should be allowed to be in place for 60 seconds. This is the most critical step in the process. Applied varnish will be dried with gentle flow of compressed air. SDF will be applied with a microbrush to all carious lesions and to all pits and fissures on posterior (molar) teeth for 60 seconds. To avoid gingival or mucosal irritation, contact of varnish with any oral tissue other than affected area will be avoided. If the application time is shorter due to unforeseen reasons reapplication will be considered.
    Other Names:
  • Riva Star
  • 38% Silver Diammine fluoride
  • SDF
  • Advanatge Arrest
  • Saforide
  • Experimental: Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish at baseline

    0.25 ml of the solution will be used which contains 12.5 mg of fluoride. Thin layer will be applied with sweeping horizontal brush strokes to all teeth present.

    Drug: Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish
    According to manufacturer, Clinpro® White Varnish can be applied to tooth surfaces where plaque is present. A prophylaxis is not required. The applicator brush provided along is used to thoroughly mix the varnish inside the single-unit dose pack, since components of all sodium fluoride varnishes are separate during storage. Excessive contact with soft tissue should be avoided. Only enough varnish to form a thin coating on the desired treatment area should be used. After application, patient should be instructed to close their mouth to set the varnish. Rinsing or suctioning immediately after application is not recommended. The operator might appreciate the formation of a thin coating on the teeth and the patient should be informed that they may feel a thin coating when rubbing the treated area with their tongue.
    Other Names:
  • ClinPro White varnish
  • Sodium fluoride with functionalized tricalcium phosphate
  • NaF-fTCP
  • Experimental: Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish at 6 months

    0.25 ml of the solution will be used which contains 12.5 mg of fluoride. Thin layer will be applied with sweeping horizontal brush strokes to all teeth present.

    Drug: Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish
    According to manufacturer, Clinpro® White Varnish can be applied to tooth surfaces where plaque is present. A prophylaxis is not required. The applicator brush provided along is used to thoroughly mix the varnish inside the single-unit dose pack, since components of all sodium fluoride varnishes are separate during storage. Excessive contact with soft tissue should be avoided. Only enough varnish to form a thin coating on the desired treatment area should be used. After application, patient should be instructed to close their mouth to set the varnish. Rinsing or suctioning immediately after application is not recommended. The operator might appreciate the formation of a thin coating on the teeth and the patient should be informed that they may feel a thin coating when rubbing the treated area with their tongue.
    Other Names:
  • ClinPro White varnish
  • Sodium fluoride with functionalized tricalcium phosphate
  • NaF-fTCP
  • Experimental: Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish at 12 months

    0.25 ml of the solution will be used which contains 12.5 mg of fluoride. Thin layer will be applied with sweeping horizontal brush strokes to all teeth present.

    Drug: Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish
    According to manufacturer, Clinpro® White Varnish can be applied to tooth surfaces where plaque is present. A prophylaxis is not required. The applicator brush provided along is used to thoroughly mix the varnish inside the single-unit dose pack, since components of all sodium fluoride varnishes are separate during storage. Excessive contact with soft tissue should be avoided. Only enough varnish to form a thin coating on the desired treatment area should be used. After application, patient should be instructed to close their mouth to set the varnish. Rinsing or suctioning immediately after application is not recommended. The operator might appreciate the formation of a thin coating on the teeth and the patient should be informed that they may feel a thin coating when rubbing the treated area with their tongue.
    Other Names:
  • ClinPro White varnish
  • Sodium fluoride with functionalized tricalcium phosphate
  • NaF-fTCP
  • Outcome Measures

    Primary Outcome Measures

    1. Caries prevalence [Baseline]

      Calculated by the frequency of participants having decayed, missing, filled surfaces of dentition

    2. Frequency distribution of caries risk [Baseline]

      Calculated using Caries Risk Assessment questionnaire, which is denoted as low, moderate or high

    3. Mean score of oral health impact [Baseline]

      Calculated using Urdu-Early Childhood Oral Health Impact Scale form, the answer for each item is on a 5-point scale. The sum score of answers to the 13 questions can range from 0-52. The impact of oral health on life activities is predicted to be greater with a higher score in the summation which denotes a poorer quality of life.

    4. Patient behaviour towards dental treatment [Baseline]

      Calculated using Frankl behaviour rating scale four category which are: definitely negative, negative, positive, definitely positive

    5. Mean score of pain experience [Baseline]

      Calculated using Wong Baker Faces Scale on a range of facial expression where 0 denotes no pain, 2, 4, 6 ,8 and 10 denotes the most painful experience

    6. Mean value of caries experience [Baseline]

      Calculated by summation of number of decayed, missing and filled surfaces of dentition

    7. Extent of selected cavitated carious lesion using ICDAS [Baseline]

      Coded according to ICDAS-2 scoring system code 3: Moderate enamel breakdown, code 4: Moderate underlying dentinal shadow 5: extensive carious lesion extending to dentin without pulpal involvement

    8. Extent of selected cavitated carious lesion using FOTI [Baseline]

      Coded using Fiber optic transillumination device corresponding to ICDAS code 3- code 5

    9. Changes in the mean score of oral health impact [6 months]

      Calculated using Urdu-Early Childhood Oral Health Impact Scale form, the answer for each item is on a 5-point scale. The sum score of answers to the 13 questions can range from 0-52. The impact of oral health on life activities is predicted to be greater with a higher score in the summation which denotes a poorer quality of life.

    10. Changes in the mean score of patient behaviour towards dental treatment [6 months]

      Calculated using Frankl behaviour rating scale four category which are: definitely negative, negative, positive, definitely positive

    11. Changes in the mean score of pain experience [6 months]

      Calculated using Wong Baker Faces Scale on a range of facial expression where 0 denotes no pain, 2, 4, 6 ,8 and 10 denotes the most painful experience

    12. Changes in the mean value of caries experience [6 months]

      Calculated by summation of number of decayed, missing and filled surfaces of dentition

    13. Extent of selected cavitated carious lesion using ICDAS [6 months]

      Coded according to ICDAS-2 scoring system code 3: Moderate enamel breakdown, code 4: Moderate underlying dentinal shadow 5: extensive carious lesion extending to dentin without pulpal involvement

    14. Extent of selected cavitated carious lesion using FOTI [6 months]

      Coded using Fiber optic transillumination device corresponding to ICDAS code 3- code 5

    15. Changes in the mean score of oral health impact [12 months]

      Calculated using Urdu-Early Childhood Oral Health Impact Scale form, the answer for each item is on a 5-point scale. The sum score of answers to the 13 questions can range from 0-52. The impact of oral health on life activities is predicted to be greater with a higher score in the summation which denotes a poorer quality of life.

    16. Changes in the mean score of patient behaviour towards dental treatment [12 months]

      Calculated using Frankl behaviour rating scale four category which are: definitely negative, negative, positive, definitely positive

    17. Changes in the mean score of pain experience [12 months]

      Calculated using Wong Baker Faces Scale on a range of facial expression where 0 denotes no pain, 2, 4, 6 ,8 and 10 denotes the most painful experience

    18. Changes in the mean value of caries experience [12 months]

      Calculated by summation of number of decayed, missing and filled surfaces of dentition

    19. Extent of selected cavitated carious lesion using ICDAS [12 months]

      Coded according to ICDAS-2 scoring system code 3: Moderate enamel breakdown, code 4: Moderate underlying dentinal shadow 5: extensive carious lesion extending to dentin without pulpal involvement

    20. Extent of selected cavitated carious lesion using FOTI [12 months]

      Coded using Fiber optic transillumination device corresponding to ICDAS code 3- code 5

    Secondary Outcome Measures

    1. Number of participants reporting adverse events [Baseline]

      The frequency of participants reporting fluoride or silver toxicity

    2. Percentage of dropouts [6 months]

      Frequency of participants which either withdraw and do not consent for follow up

    3. Number of participants reporting adverse events [6 months]

      The frequency of participants reporting fluoride or silver toxicity

    4. Percentage of dropouts [12 months]

      Frequency of participants which either withdraw and do not consent for follow up

    5. Number of participants reporting adverse events [12 months]

      The frequency of participants reporting fluoride or silver toxicity

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    4 Years to 6 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:

    Children will be invited to participate in the trial if they fulfil the entire selection criteria as described below:

    • 4 to 6 years-of-age

    • Identification of one or more carious primary molars without involvement of the pulp confirmed by bitewing radiographs

    • Up to three teeth per each participant will be selected for intervention

    • Has normal salivary flow rate

    • Does not consume medications regularly for any medical condition

    • Has not or will not receive any fluoride therapy or relevant dental therapy from other dental sources within the last six months

    Exclusion criteria:
    Children will be excluded from the trial if they fulfil any of the following criteria:
    • Presence of any pain, ulceration, fistula/sinus or an abscess

    • Premature hypermobility of carious teeth which can be potentially included in the study

    • History of allergy to any product containing silver compounds

    • Siblings of the participants will not be allowed to participate to ensure any chance of ECOHIS duplication.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Crescent Montessori School Lahore Punjab Pakistan 54600

    Sponsors and Collaborators

    • Universiti Sains Malaysia
    • 3M ESPE
    • SDI Limited

    Investigators

    • Principal Investigator: Anas Imran Arshad, MSc., BDS, Universiti Sains Malaysia

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    ANAS IMRAN ARSHAD, Principal Investigator, Universiti Sains Malaysia
    ClinicalTrials.gov Identifier:
    NCT05772039
    Other Study ID Numbers:
    • USM/JEPeM/20010069
    First Posted:
    Mar 16, 2023
    Last Update Posted:
    Mar 16, 2023
    Last Verified:
    Mar 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by ANAS IMRAN ARSHAD, Principal Investigator, Universiti Sains Malaysia
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 16, 2023